Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community
Pharm. pract. (Granada, Internet)
; 16(3): 0-0, jul.-sept. 2018. tab, graf
Artigo
em Inglês
| IBECS
| ID: ibc-174804
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Background:
Benzodiazepine and z-hypnotic prescribing has slowly decreased over the past 20 years, however long-term chronic prescribing still occurs and is at odds with prescribing guidance.Objectives:
To identify the pattern of benzodiazepine and z-hypnotic prescribing in psychiatric inpatients at discharge and 12 months post-discharge.Methods:
Retrospective observational longitudinal cohort study of patients admitted to two adult psychiatric wards between June and November 2012 (inclusive) who were discharged with a prescription for a benzodiazepine or z-hypnotic drug. Routinely collected prescription data available from NHS Scotland Prescribing Information System was used to identify and follow community prescribing of benzodiazepine and z-hypnotics for a 12 month period post-discharge. Data were entered in Excel® and further analysed using SPSS 23. Ethical approval was not required for this service evaluation however Caldicott Guardian approval was sought and granted.Results:
Eighty patients were admitted during the study period however only those patients with a single admission were included for analysis (n=74). Thirty per cent (22/74) of patients were prescribed a benzodiazepine or z-hypnotics at discharge; 14 of whom received'long-term' benzodiazepine and z-hypnotics i.e. continued use over the 12 month period. Seven patients received a combination of anxiolytics and hypnotics (e.g., diazepam plus temazepam or zopiclone). Long-term use was associated with a non-significant increase in median benzodiazepine or z-hypnotic dose, expressed as diazepam equivalents.Conclusions:
One in three patients were prescribed a benzodiazepine or z-hypnotics at discharge with 1 in 5 receiving continuous long-term treatment (prescriptions) for 12 months post-discharge. As chronic long-term B-Z prescribing and use still remains an issue, future strategies using routine patient-level prescribing data may support prescribers to review and minimise inappropriate long-term prescribingRESUMEN
No disponible
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Contexto em Saúde:
ODS3 - Meta 3.8 Atingir a cobertura universal de saúde
/
Agenda de Saúde Sustentável para as Américas
Problema de saúde:
Arranjos de Entrega
/
Objetivo 6: Sistemas de informação em saúde
Base de dados:
IBECS
Assunto principal:
Assistência Farmacêutica
/
Benzodiazepinas
/
Hipnóticos e Sedativos
/
Transtornos Mentais
Tipo de estudo:
Estudo diagnóstico
/
Guia de prática clínica
/
Estudo observacional
/
Fatores de risco
Aspecto:
Aspectos éticos
Limite:
Adolescente
/
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Pharm. pract. (Granada, Internet)
Ano de publicação:
2018
Tipo de documento:
Artigo
Instituição/País de afiliação:
Al-Mustansiriya University/Iraq
/
NHS Greater Glasgow & Clyde/United Kingdom
/
NHS Greater Glasgow and Clyde/United Kingdom
/
University of Strathclyde/United Kingdom